Gale Smith
53Patents
14h-index
37Co-inventors
84Inventor score
Filing activity: May 27, 1983 → Aug 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4745051A | Method for producing a recombinant baculovirus expression vector | Chemistry; Metallurgy | 218 | Expired |
| US4879236A | Method for producing a recombinant baculovirus expression vector | Chemistry; Metallurgy | 168 | Expired |
| US5858368A | Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein | Emerging Cross-Sectional Technologies | 145 | Expired |
| US5762939A | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus | Emerging Cross-Sectional Technologies | 138 | Expired |
| US6245532A | Method for producing influenza hemagglutinin multivalent vaccines | Emerging Cross-Sectional Technologies | 52 | Expired |
| US10953089B1 | Coronavirus vaccine formulations | Chemistry; Metallurgy | 35 | Active |
| US8080255B2 | Functional influenza virus like particles (VLPs) | Chemistry; Metallurgy | 33 | Active |
| US6103526A | Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using | Chemistry; Metallurgy | 32 | Expired |
| US7598075B2 | Apparatus and methods for producing and using high-density cells and products therefrom | Chemistry; Metallurgy | 25 | Expired |
| US6224882A | Insect cells or fractions as adjuvant for antigens | Chemistry; Metallurgy | 21 | Expired |
| US8506967B2 | Functional influenza virus like particles (VLPs) | Chemistry; Metallurgy | 19 | Active |
| US8715692B2 | Modified RSV F proteins and methods of their use | Chemistry; Metallurgy | 18 | Active |
| US8551756B2 | Avian influenza chimeric VLPS | Emerging Cross-Sectional Technologies | 17 | Active |
| US10022437B2 | Modified RSV F proteins and methods of their use | Chemistry; Metallurgy | 17 | Active |
| US9050290B2 | Functional influenza virus like particles (VLPs) | Chemistry; Metallurgy | 14 | Active |
| US10426829B2 | Vaccine compositions having improved stability and immunogenicity | Chemistry; Metallurgy | 13 | Active |
| US8951537B2 | Functional influenza virus-like particles (VLPs) | Chemistry; Metallurgy | 12 | Active |
| US9180180B2 | Functional influenza virus-like particles (VLPs) | Chemistry; Metallurgy | 11 | Active |
| US8992939B2 | Highly efficient influenza matrix (M1) proteins | Chemistry; Metallurgy | 11 | Active |
| US9675685B2 | Modified RSV F proteins and methods of their use | Chemistry; Metallurgy | 10 | Active |
| US9464276B2 | Highly efficient influenza matrix (M1) proteins | Chemistry; Metallurgy | 7 | Active |
| US7879601B2 | Apparatus and methods for producing and using high-density cells and products therefrom | Chemistry; Metallurgy | 7 | Active |
| US9731000B2 | Modified RSV F proteins and methods of their use | Chemistry; Metallurgy | 7 | Active |
| US9717786B2 | Modified RSV F proteins and methods of their use | Chemistry; Metallurgy | 7 | Active |
| US11253585B2 | Vaccine compositions having improved stability and immunogenicity | Chemistry; Metallurgy | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.